新功能、新界面、新体验,扫描即可下载生物谷APP!
首页 » BIOON报道 » 印度Dr. Reddy公司召回产品拖累沃尔玛等零售业巨头

印度Dr. Reddy公司召回产品拖累沃尔玛等零售业巨头

来源:生物谷 2013-08-27 19:23

2013年8月27日讯 /生物谷BIOON/ --今日,在FDA宣布印度仿制药生产商Dr. Reddy's Laboratories 公司生产的一些产品中出现了假单胞菌检测呈阳性的结果,公司宣布召回可能感染的商品。此举也影响了沃尔玛、沃尔格森和超价公司。前者是美国最大的零售业巨头,后两者是著名的连锁零售药店公司。三家企业都有其自有品牌的盐酸雷尼替丁(治疗胃溃疡等疾病)。沃尔玛的Equate、沃尔格森的Wal-Zan和Equaline三种同类药物也都被迫下架。(生物谷Bioon.com)

详细英文报道:

Walmart, Walgreens and Supervalu are all having their private label brands of the gastroesophageal reflux drug ranitidine hydrochloride pulled off of shelves after Indian generics maker Dr. Reddy's Laboratories found microbial contamination of some of the products. According to the FDA notice, a lot of "raw material" used in the manufacture of ranitidine tested positive for Pseudomonas sp. bacteria. The FDA said it is sold by Walmart as Equate, by Walgreens as Wal-Zan and by Supervalu as Equaline. Last year, Dr. Reddy's recalled some lots of its generic of the schizophrenia drug Seroquel from the U.S. after tests raised questions about its sterility.

 

温馨提示:87%用户都在生物谷APP上阅读,扫描立刻下载! 天天精彩!


相关标签

最新会议 培训班 期刊库